---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-035590"
form_type: "8-K"
ticker: "ELUT"
cik: "0001708527"
company_name: "ELUTIA INC."
filed_at: "2023-03-22T23:59:59+00:00"
generated_at: "2026-06-17T21:27:26.693900+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Record FY2022 revenue $49.2M; FDA delays CanGaroo RM; Q4 net loss narrows

## Summary
- FY2022 net sales $49.2M (+4% YoY); ex-discontinued FiberCel, current product sales up 16%.
- Q4 net sales $12.7M (+17% YoY); CanGaroo and SimpliDerm combined grew 30%.
- FDA delayed clearance of CanGaroo RM Antibacterial Envelope; company cutting costs to extend cash runway.
- Q4 gross margin improved to 39% (non-GAAP 46%); net loss per share $0.38 vs $0.82 YoY.
- Entered U.S. distribution agreement with Sientra for SimpliDerm; cash $17.0M at Dec 31, 2022.

## SEC filing metadata
- accession: 0001104659-23-035590
- form_type: 8-K
- ticker: ELUT
- cik: 0001708527
- company_name: ELUTIA INC.
- filed_at: 2023-03-22T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708527/000110465923035590/0001104659-23-035590-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708527/000110465923035590/tm2310291d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-035590
- JSON: https://secwatch.observer/filing/0001104659-23-035590.json
- Plain text: https://secwatch.observer/filing/0001104659-23-035590.txt

## Key facts
- Earnings Releases
  ELUTIA INC. reported the fourth quarter ended December 31, 2022 results: revenue $12.7 million, net income Net loss was $5.4 million, EPS Net loss per share in the fourth quarter of 2022 was $0.38 per share.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $12.7 million
  - Net income: Net loss was $5.4 million
  - EPS: Net loss per share in the fourth quarter of 2022 was $0.38 per share
  - Result: reported results
  source text: Net sales for the fourth quarter of 2022 were $12.7 million, an increase of 17% compared to the fourth quarter of 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708527/000110465923035590/0001104659-23-035590-index.htm
- Earnings Releases
  ELUTIA INC. reported the full year ended December 31, 2022 results: revenue $49.2 million, net income Net loss was $32.9 million, EPS Loss per share in the full year 2022 was $2.38 per share.
  - Period: the full year ended December 31, 2022
  - Revenue: $49.2 million
  - Net income: Net loss was $32.9 million
  - EPS: Loss per share in the full year 2022 was $2.38 per share
  - Result: reported results
  source text: Net sales for the full year 2022 were $49.2 million, an increase of 4% compared to the full year 2021 net sales of $47.4 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708527/000110465923035590/0001104659-23-035590-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.